Wall Street Experts
ver. ZuMIgo(08/25)
Harbin Gloria Pharmaceuticals Co., Ltd
Rachunek Zysków i Strat
Przychody TTM (mln): 2 407
EBIT TTM (mln): 111
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
Rok finansowy |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
164 |
276 |
430 |
575 |
546 |
711 |
1,308 |
1,906 |
2,681 |
2,984 |
3,042 |
5,481 |
5,054 |
3,055 |
3,145 |
3,108 |
2,626 |
2,441 |
Przychód Δ r/r |
0.0% |
67.9% |
56.0% |
33.8% |
-5.1% |
30.1% |
83.9% |
45.7% |
40.7% |
11.3% |
1.9% |
80.2% |
-7.8% |
-39.6% |
3.0% |
-1.2% |
-15.5% |
-7.1% |
Marża brutto |
65.7% |
63.8% |
56.4% |
53.2% |
48.6% |
63.6% |
77.1% |
63.0% |
63.2% |
58.7% |
70.6% |
74.5% |
73.4% |
74.0% |
73.6% |
76.9% |
58.3% |
53.5% |
EBIT (mln) |
77 |
109 |
152 |
181 |
139 |
198 |
201 |
491 |
762 |
778 |
342 |
172 |
320 |
785 |
157 |
-112 |
175 |
285 |
EBIT Δ r/r |
0.0% |
40.7% |
39.6% |
19.4% |
-23.5% |
42.5% |
2.0% |
143.9% |
55.2% |
2.1% |
-56.1% |
-49.7% |
86.1% |
145.0% |
-80.0% |
-171.2% |
-256.9% |
62.7% |
EBIT (%) |
47.1% |
39.4% |
35.3% |
31.5% |
25.4% |
27.8% |
15.4% |
25.8% |
28.4% |
26.1% |
11.2% |
3.1% |
6.3% |
25.7% |
5.0% |
-3.6% |
6.7% |
11.7% |
Koszty finansowe (mln) |
2 |
3 |
3 |
4 |
0 |
0 |
18 |
27 |
88 |
109 |
167 |
156 |
146 |
89 |
71 |
69 |
43 |
10 |
EBITDA (mln) |
80 |
122 |
169 |
202 |
157 |
187 |
244 |
669 |
1,079 |
1,188 |
778 |
827 |
502 |
934 |
301 |
19 |
324 |
385 |
EBITDA(%) |
48.7% |
44.3% |
39.4% |
35.2% |
28.7% |
26.2% |
18.7% |
35.1% |
40.3% |
39.8% |
25.6% |
15.1% |
9.9% |
30.6% |
9.6% |
0.6% |
12.3% |
15.8% |
Podatek (mln) |
2 |
3 |
23 |
28 |
20 |
36 |
40 |
92 |
125 |
130 |
66 |
50 |
51 |
156 |
32 |
20 |
48 |
41 |
Zysk Netto (mln) |
75 |
106 |
130 |
155 |
117 |
165 |
227 |
444 |
665 |
717 |
310 |
126 |
-2,655 |
400 |
45 |
-290 |
120 |
233 |
Zysk netto Δ r/r |
0.0% |
41.7% |
22.9% |
18.8% |
-24.5% |
41.0% |
37.6% |
95.7% |
49.8% |
7.8% |
-56.8% |
-59.3% |
-2208.9% |
-115.1% |
-88.7% |
-742.8% |
-141.6% |
93.4% |
Zysk netto (%) |
45.6% |
38.4% |
30.3% |
26.9% |
21.4% |
23.2% |
17.3% |
23.3% |
24.8% |
24.0% |
10.2% |
2.3% |
-52.5% |
13.1% |
1.4% |
-9.3% |
4.6% |
9.5% |
EPS |
0.13 |
0.0673 |
0.0827 |
0.084 |
0.056 |
0.0787 |
0.11 |
0.21 |
0.31 |
0.33 |
0.14 |
0.0573 |
-1.21 |
0.18 |
0.0205 |
-0.13 |
0.0547 |
0.11 |
EPS (rozwodnione) |
0.13 |
0.0673 |
0.0827 |
0.084 |
0.056 |
0.0787 |
0.11 |
0.21 |
0.3 |
0.33 |
0.14 |
0.0573 |
-1.21 |
0.18 |
0.0205 |
-0.13 |
0.0547 |
0.1 |
Ilośc akcji (mln) |
569 |
1,574 |
1,575 |
1,842 |
2,087 |
2,095 |
2,125 |
2,100 |
2,145 |
2,179 |
2,198 |
2,197 |
2,198 |
2,198 |
2,198 |
2,198 |
2,200 |
2,198 |
Ważona ilośc akcji (mln) |
569 |
1,574 |
1,575 |
1,842 |
2,087 |
2,095 |
2,126 |
2,116 |
2,196 |
2,198 |
2,198 |
2,197 |
2,198 |
2,198 |
2,198 |
2,198 |
2,200 |
2,262 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |